Nesiritide test for hard-to-control blood pressure
Part of Heart & circulation clinical trials.
This Phase 1/2 study tests nesiritide, a medicine that affects blood vessels and heart strain, to see if it can improve blood pressure control in people with hypertension. It’s mainly for people whose blood pressure stays high even during the day despite medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high blood pressure (clinic top number at least 120) and you already take at least one blood pressure medicine
- Your blood pressure medicine dose has been unchanged for the last 2 weeks
- Your average daytime blood pressure is over 115 on a 24-hour blood pressure monitor
- You do not have heart failure, or any very weak heart pumping (ejection fraction 40% or less)
- You have no recent major heart or stroke problems and no unstable heart symptoms recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether timing blood pressure medications (based on your natural daily body rhythms) can improve blood pressure control. It’s designed for adults with moderately high blood pressure and focuses on who may benefit from a more precise schedule.
This study is for people with high blood pressure who are taking or about to start the medication Nebilet. It will track how well Nebilet controls blood pressure in real-world settings, including people with other heart conditions.
This trial tests whether stimulating nerves around the kidney can lower blood pressure in people whose high blood pressure stays uncontrolled despite treatment. It may help by improving how the kidneys and blood vessels regulate blood pressure.
This trial tests a procedure called renal denervation to lower blood pressure in people whose medication isn't enough. It uses a special catheter to calm nerves near the kidneys that may be overactive.
This study looks at how mineralocorticoid-related hormone signaling affects small heart blood vessels and how efficiently the heart works in people with high blood pressure. It may help doctors understand which treatments could improve heart function in hypertension.
This study tests a new medication, RTN-001, for people whose blood pressure remains high even when taking multiple blood pressure medications. The goal is to see if this drug can lower blood pressure more effectively.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.